Evaluating liver steatosis and fibrosis is important for patients with non-alcoholic fatty liver
disease. Although liver biopsy and pathological assessment is the gold standard for these …

Nonalcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease
worldwide. Although it has become one of the leading causes of cirrhosis and hepatocellular …

Liver fibrosis is a histological hallmark of most chronic liver diseases, which can progress to
cirrhosis and liver failure, and predisposes to hepatocellular carcinoma. Accurate diagnosis …

Background Short-time usage of direct-acting antiviral agents (DAA) limited knowledge
regarding histological outcomes and predictive values of noninvasive measurements in …

Objective Severe liver damage is associated with worse outcome in COVID-19. Our aim was
to explore the degree of liver damage, liver stiffness (LS) and severity of illness in patients …

Noninvasive detection of cirrhosis via vibration‐controlled transient elastography (VCTE)
has revolutionized the management of chronic hepatitis B virus (HBV) and hepatitis C virus …

Abstract Background & Aims Although transient elastography (TE) is used to determine liver
stiffness as a surrogate to hepatic fibrosis, the normal range in children is not well defined …

Nonalcoholic fatty liver disease (NAFLD) affects at least 25% of the general adult population
worldwide. Because only a fraction of the patients would develop liver-related complications …

Portal hypertension (PH) is a spectrum of complications of chronic liver disease (CLD) and
cirrhosis, with manifestations including ascites, gastroesophageal varices, splenomegaly …

Background: Liver stiffness measurement (LSM) is crucial for appropriate fibrosis staging in
patients with ongoing hepatitis C virus (HCV) infection. However, there is still an ongoing …